Your browser doesn't support javascript.
loading
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
van Hellemond, Irene E G; Vriens, Ingeborg J H; Peer, Petronella G M; Swinkels, Astrid C P; Smorenburg, Carolien H; Seynaeve, Caroline M; van der Sangen, Maurice J C; Kroep, Judith R; de Graaf, Hiltje; Honkoop, Aafke H; Erdkamp, Frans L G; van den Berkmortel, Franchette W P J; de Boer, Maaike; de Roos, Wilfred K; Linn, Sabine C; Imholz, Alexander L T; Tjan-Heijnen, Vivianne C G.
Afiliación
  • van Hellemond IEG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Vriens IJH; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Peer PGM; Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Swinkels ACP; Clinical Research Department, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, The Netherlands.
  • Smorenburg CH; Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands.
  • Seynaeve CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  • Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Graaf H; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Honkoop AH; Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands.
  • Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Center, Sittard, The Netherlands.
  • van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • de Boer M; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • de Roos WK; Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands.
  • Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands.
  • Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
Int J Cancer ; 145(1): 274-283, 2019 07 01.
Article en En | MEDLINE | ID: mdl-30588619
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ovario / Tamoxifeno / Neoplasias de la Mama / Anastrozol Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ovario / Tamoxifeno / Neoplasias de la Mama / Anastrozol Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos